Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: November 2008
-
By Jason Derry — Icon plc has announced its acquisition of Prevalere Life Sciences Inc., a move that will expand Icon's bioanalytics and immunoassay business in the United States. Prevalere, identified in the announcement as a wholly owned subsidiary of ORS Labs Inc, is a New York-based contract research organization that provides consulting and…
-
By Donald Zuhn — As part of its ongoing "Conversations With" series, the Washington Legal Foundation (WLF) recently made available its latest question-and-answer offering, which examines the ongoing evolution of intellectual property rights in the United States and internationally. In the paper, entitled "The Changing Legal Landscape For Intellectual Property," former Attorney General and…
-
By Christopher P. Singer — Professor Douglas Lichtman (at right) from the UCLA School of Law contacted Patent Docs to let us know about a free audio podcast regarding the recent Federal Circuit decision in In re Bilski, which is available for download at the Intellectual Property Colloquium. The one hour program includes commentary on…
-
By Donald Zuhn — As we reported last month, the District Court for the District of Columbia issued an important decision on September 30th that could impact the manner in which Patent Term Adjustment (PTA) determinations are made. In Wyeth v. Dudas, the District Court granted summary judgment in favor of Wyeth, determining that…
-
By Kevin E. Noonan — Under Secretary of Commerce and U.S. Patent and Trademark Office Director Jon Dudas (at right) announced today two changes in Patent Office management, occasioned by the early departure of Margaret Peterlin, Deputy under Secretary of Commerce and Deputy PTO Director (see "Deputy Director Peterlin Announces Resignation") on her leaving. …
-
By Donald Zuhn — Last week, we reviewed prior Patent Docs reports discussing some aspects of President-elect Barack Obama's technology platform, including his positions on patent issues and follow-on biologics (see "A Second Look at President-elect Obama's Technology Platform"). We also reported on the response by some in the patent community to last week's…
-
By Donald Zuhn — Last month, Epitomics Inc. announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,431,927, which is directed to monoclonal antibodies that neutralize TNF-alpha activity. The Burlingame, California-based biotech company also announced that the USPTO has issued U.S. Patent No. 7,429,487, which is directed to a rabbit-derived…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Bayer Healthcare LLC v. Norbrook Laboratories Limited et al.2:08-cv-02556; filed November 6, 2008 in the District Court of Kansas Infringement of U.S.…
-
November 10-11, 2008 – Patent Litigation 2008 (Practising Law Institute) – Atlanta, GA November 11-13, 2008 – 4th Biosimilars conference (Visiongain) – Philadelphia, PA November 12-14, 2008 – Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements (American Conference Institute) – New York, NY November 17-18, 2008 – Pharmaceutical and Biotech Patent Opinion Writing*** (American Conference Institute)…
-
Law Education Institute, Inc. (LEI) will be holding the 26th Annual National CLE Conference on January 3-7, 2009 in Vail, Colorado. The Intellectual Property program of the conference, which will be held at the Vail Marriott Mountain Resort, will offer presentations on a number of topics, including: • In-house analysis — Strategic considerations for filing…
Patent Docs 